U.S. market Closed. Opens in 15 hours 15 minutes

DMAQ | Deep Medicine Acquisition Corp. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-03-312022-03-31
RevenueN/AN/A
Cost of Revenue60.00K60.00K
Gross Profit-60.00K-60.00K
Operating Expenses2.11M409.91K
Selling, General & Admin1.91M409.91K
Research & DevelopmentN/AN/A
Other Operating Expenses200.00K60.00K
Operating Income-342.66K-461.65K
Other Expenses / Income1.82M47.60K
Before Tax Income-342.66K-414.05K
Income Tax Expenses57.57K-55.87K
Net Income-400.23K-358.18K
Interest ExpensesN/A8.27K
Basic Shares Outstanding2.31M8.74M
Diluted Shares Outstanding2.31M8.74M
EBITDA-3.99M-405.78K
EBITDA Margin0.00%0.00%
EBIT-342.66K-405.78K
EBIT Margin0.00%0.00%
Financial Year End2023-03-312022-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙